With HarrisMartin's Testosterone Therapy Litigation Report, you will be the first to know about critical developments in this emerging area of drug litigation. The report includes coast-to-coast coverage of AndroDerm, Depo Testosterone, AndroGel, Testim and other Testosterone products Click Here to Subscribe Now). This publication is offered exclusively online.
Current Drugs & Medical Devices subscribers receive this supplement at no extra charge. To set up access to the report, call (800) 496-4319. Those who do not currently subscribe to the Drugs & Medical Devices report can Click Here for Access
Testosterone Therapy - Issue: 1
Eli Lilly Says Distributor of Axiron Testosterone Product Can’t be Sued Over Cardiovascular Risks
Class Action Lawsuit Says Makers of AndroDerm, Depo Testosterone Hid Risks of Cardiac Events, Stroke
Plaintiffs Ask JPML to Consolidate All Testosterone Therapy Drug Litigation
Plaintiffs File Motion to Consolidate All Federal Lawsuits Linking AndroGel Testosterone Therapy to Heart Attacks, Strokes
Makers of Testosterone Patch Androderm Accused of Concealing Risks of Cardiac Events, Stroke
Suits Accuse Auxilium, GSK, of Failing to Warn of Side Effects Caused by Testosterone Drug Testim
Lawsuit Says Auxilium Pharmaceuticals Testosterone Drug Testim Caused Calif. Man’s Stroke
Suit Says Makers of Testosterone Drug AndroGel Hid Risks of Blood Clots, Stroke
